Research In Brief
Physician conflict-of-interest disclosure: About 79% of physicians self-reported conflicts of interest for payments directly related to presentations at the 2008 American Academy of Orthopedic Surgeons annual meeting, according to an article published in the Oct. 8 New England Journal of Medicine. The study, led by Kanu Okike, Brigham and Women's Hospital/Massachusetts General Hospital, found that the overall disclosure rate was 71.2%. For payments indirectly related to an AAOS presentation, the rate was 50%. According to a multivariate analysis, it was more likely for a payment to be disclosed if it exceeded $10,000, was directed toward an individual doctor or included an in-kind component. The study was based on physician payments disclosed on the Web sites of Biomet, Johnson & Johnson/DePuy, Stryker, Smith & Nephew and Zimmer. The five companies were required to make physician payments public as part of a 2007 settlement with the Department of Justice (1"The Gray Sheet" Oct. 1, 2007)
More from Archive
Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.
Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.
In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.
More from Medtech Insight
Diabetes company Insulet announced that former longtime J&J executive Ashley McEvoy will succeed Jim Hollingshead as president and CEO effective today. Analysts applauded the appointment, noting McEvoy’s strong background in medtech and diabetes.
Medtech Insight sat down with Jared Bunch, chair of AF Center of Excellence Task Force, at HRS 2025 to discuss the newly HRS released framework for Afib Center of Excellence and get his perspective on the role industry could play to help clinicians improve patient outcomes.
Former FDA Commissioner Robert Califf urged the Heart Rhythm Society to engage actively amid federal funding cuts. He highlighted collaboration among researchers, advocates for healthcare integration, and the importance of addressing social determinants of health, while discussing lobbying strategies and the challenges faced by medtech companies.